GO:0072538 T-helper 17 type immune response: Cytokine Network, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0072538 (T-helper 17 type immune response) describes a CD4+ T-cell-driven immune response that is associated with resistance to intracellular bacteria and plays a key role in inflammation and tissue injury.
• Th17 cells are defined by production of signature cytokines, most notably IL-17, IL-21 and IL-22, which orchestrate neutrophil recruitment and epithelial barrier activation.
• Dysregulated Th17 responses are linked to autoimmune and inflammatory conditions such as psoriasis, multiple sclerosis and arthritis.
• Th17 differentiation depends on transcription factors including RORγt (RORC) and is influenced by the gut microbiota and local cytokine milieu.
• Th17-type immunity is also implicated in asthma, Hashimoto's thyroiditis and ocular surface disease, where IL-17 and related cytokines contribute to tissue injury [3,4,7,8].
• CRISPR knockout, knock-in and overexpression models enable causal testing of Th17-related genes in primary T cells and reporter lines.
Description
The Gene Ontology term GO:0072538, T-helper 17 type immune response, defines a biological process in which CD4+ T helper cells of the Th17 lineage coordinate an inflammatory response characterized by production of interleukin-17 (IL-17), IL-21 and IL-22. This response is associated with resistance to intracellular bacteria and is a central driver of inflammation and tissue injury in autoimmune and inflammatory diseases. Understanding the molecular and cellular players of this process is essential for immunologists, translational researchers and drug developers targeting Th17-mediated pathology [1,5].
T-helper 17 type immune response At A Glance
| GO ID | GO:0072538 |
|---|---|
| GO term | T-helper 17 type immune response |
| Ontology | biological_process |
| Synonym | Th17 immune response |
| Major function | Orchestration of inflammatory responses via IL-17, IL-21 and IL-22, associated with resistance to intracellular bacteria and tissue injury |
| Key cell type | CD4+ T helper 17 (Th17) cells |
| Signature cytokines | IL-17, IL-21, IL-22 |
| Associated diseases | Psoriasis, multiple sclerosis, arthritis, asthma, Hashimoto's thyroiditis [1,3,7,8] |
| Key transcription factor | RORγt (encoded by RORC) |
What Is GO:0072538?
GO:0072538 describes an immune response that is associated with resistance to intracellular bacteria and has a key role in inflammation and tissue injury. It is typically orchestrated by the production of particular cytokines by T-helper 17 cells, most notably interleukin-17, IL-21 and IL-22, and is associated with pathological autoimmune conditions such as multiple sclerosis, arthritis and psoriasis.
Why Is T-helper 17 type immune response Important in Cell Biology?
Th17-type immune responses are central to host defense against intracellular bacteria but also drive chronic inflammation and tissue damage in autoimmune diseases such as psoriasis, multiple sclerosis and arthritis [1,5]. Because IL-17, IL-21 and IL-22 are actionable drug targets, understanding the regulation and effector functions of this GO term is critical for developing new therapies [1,5].
• Th17 cells and their cytokines are major drivers of psoriasis pathogenesis.
• IL-17 and related cytokines contribute to airway inflammation in asthma [3,7].
• Th17 responses are implicated in autoimmune thyroid disease such as Hashimoto's thyroiditis.
• Th17-type immunity participates in immune responses to injury and links to eye disease.
• RORγt+ cells instruct gut microbiota-specific Treg differentiation, showing Th17-Treg crosstalk.
• Th17 responses are associated with resistance to intracellular bacteria.
• Dysregulated Th17 immunity contributes to multiple sclerosis and arthritis.
• Th17 cytokines promote neutrophil recruitment and epithelial activation.
• Th17 cells are a target for biologic therapies in inflammatory diseases [1,7].
• Understanding Th17 biology aids vaccine and immunotherapy design.
What Happens During T-helper 17 type immune response?
Th17 cell differentiation and lineage commitment
In simple terms: Naive CD4+ T cells can become Th17 cells when they receive specific signals.
In the presence of polarizing cytokines, naive CD4+ T cells differentiate into Th17 cells, a process dependent on the transcription factor RORγt (RORC) [5,6]. This differentiation is influenced by the local cytokine environment and by signals from the gut microbiota.
Production of signature cytokines IL-17, IL-21 and IL-22
In simple terms: Once formed, Th17 cells release cytokines that drive inflammation.
Th17 cells are characterized by production of IL-17, IL-21 and IL-22, which mediate many of the effector functions of this immune response. These cytokines act on epithelial cells, neutrophils and other immune cells to promote inflammation and tissue responses.
Effector functions: neutrophil recruitment and barrier activation
In simple terms: Th17 cytokines call in neutrophils and activate barrier tissues.
IL-17 and related cytokines promote neutrophil recruitment and activate epithelial cells, contributing to host defense against intracellular bacteria but also to tissue injury in autoimmune settings.
Crosstalk with regulatory T cells and microbiota
In simple terms: Th17 responses are balanced by regulatory T cells and influenced by gut microbes.
RORγt+ cells can instruct gut microbiota-specific regulatory T cell differentiation, illustrating a regulatory axis that modulates Th17 responses. This crosstalk helps maintain immune homeostasis and prevents excessive inflammation.
Pathological amplification in autoimmune disease
In simple terms: When Th17 responses go unchecked, they can damage tissues.
In conditions such as psoriasis, multiple sclerosis and arthritis, exaggerated Th17 responses and their cytokines drive chronic inflammation and tissue injury [1,5]. Targeting IL-17 and related pathways has therapeutic benefit in these diseases.
Key Genes Involved in GO:0072538 T-helper 17 type immune response
The following genes and proteins are central to the T-helper 17 type immune response and are frequently studied in immunology research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL17A | Signature Th17 cytokine | Target in psoriasis and autoimmune disease [1,5] |
| IL17F | Th17 cytokine related to IL-17A | Contributes to mucosal immunity and inflammation |
| IL21 | Th17 cytokine | Regulates T cell and B cell responses |
| IL22 | Th17 cytokine | Acts on epithelial cells to promote barrier function |
| RORC | Transcription factor RORγt | Master regulator of Th17 differentiation |
| STAT3 | Signal transducer | Required for Th17 differentiation |
| IL23R | Receptor for IL-23 | Promotes Th17 maintenance and pathogenicity |
| IL6 | Cytokine | Induces Th17 differentiation |
| TGFB1 | Cytokine | Promotes Th17 differentiation in combination with IL-6 |
| IL1B | Cytokine | Enhances Th17 responses |
| CCR6 | Chemokine receptor | Marks Th17 cells and guides migration |
| IL17RA | Receptor for IL-17 | Mediates IL-17 signaling in target cells |
| IL17RC | Receptor for IL-17 | Part of IL-17 receptor complex |
| FOXP3 | Regulatory T cell transcription factor | Balances Th17 responses |
| AHR | Aryl hydrocarbon receptor | Modulates Th17 differentiation |
| BATF | Transcription factor | Cooperates with RORγt in Th17 cells |
| IRF4 | Transcription factor | Supports Th17 differentiation |
How Is T-helper 17 type immune response Regulated?
Th17 differentiation and effector function are regulated by a network of cytokines (IL-6, TGF-β, IL-1β, IL-23), transcription factors (RORγt, STAT3, BATF, IRF4) and environmental cues such as the gut microbiota [5,6]. RORγt+ cells can also instruct regulatory T cell differentiation, providing a counter-regulatory mechanism.
T-helper 17 type immune response and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL17A | Psoriasis, autoimmune inflammation | IL17A knockout mouse or human T cell KO |
| IL23R | Psoriasis, inflammatory bowel disease | IL23R knock-in or KO models |
| RORC | Th17 differentiation, autoimmunity | RORC knockout or reporter knock-in |
| IL21 | Autoimmune disease, asthma | IL21 overexpression or KO |
| IL22 | Barrier immunity, psoriasis | IL22 knockout or transgenic overexpression |
Psoriasis
Psoriasis is a chronic inflammatory skin disease in which Th17 cells and IL-17 play a central pathogenic role. Targeting IL-17 or its receptor has proven effective in treating psoriasis, underscoring the clinical importance of GO:0072538.
Asthma
Th17 cells and their cytokines contribute to airway inflammation in asthma, particularly in severe or steroid-resistant forms [3,7]. IL-17 promotes neutrophil recruitment and airway remodeling.
Autoimmune thyroid disease
Hashimoto's thyroiditis involves immune-mediated destruction of the thyroid, with Th17 cells and IL-17 implicated in disease pathogenesis.
Ocular surface disease
Immune responses to injury, including Th17-type responses, are linked to eye diseases such as dry eye and corneal inflammation.
From T-helper 17 type immune response-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a gene drive Th17 differentiation? | CRISPR knockout in primary human CD4+ T cells |
| Does a variant alter IL-17 production? | Point mutation knock-in in T cell line |
| Can we track Th17 cells in vivo? | RORC-tdTomato or IL17A-reporter knock-in mouse |
| Does overexpression of a cytokine worsen inflammation? | Transgenic overexpression in mouse models |
| Which genes regulate Th17 pathogenicity? | CRISPR library screening in T cells |
| How does microbiota affect Th17 responses? | Germ-free or gnotobiotic mouse models |
How to Study the T-helper 17 type immune response Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | IL-17, IL-21, IL-22 production | Th17 cell quantification |
| RNA-seq | Transcriptional profile | Th17 differentiation studies |
| CRISPR knockout | Gene function | Causal gene testing |
| CRISPR knock-in | Variant effects | Point mutation modeling |
| ELISA | Cytokine secretion | Patient sample analysis |
| Immunohistochemistry | Tissue IL-17 expression | Psoriasis skin biopsies |
| EAE model | Autoimmune neuroinflammation | Multiple sclerosis research |
| Imiquimod model | Psoriasis-like skin inflammation | Psoriasis research |
Flow cytometry and cytokine profiling
Flow cytometry can identify Th17 cells by intracellular staining for IL-17, IL-21 and IL-22, and is widely used to quantify Th17 responses in patient samples and mouse models.
RNA sequencing and transcriptomics
RNA-seq of Th17 cells under different polarizing conditions reveals transcriptional programs controlled by RORγt and other factors [5,6].
CRISPR screening
Pooled CRISPR screens in primary T cells can identify genes that regulate Th17 differentiation and cytokine production.
Animal models of autoimmunity
Experimental autoimmune encephalomyelitis (EAE) and imiquimod-induced psoriasis models are used to study Th17-mediated pathology [1,5].
How CRISPR Can Be Used to Study GO:0072538 T-helper 17 type immune response
Knockout
CRISPR knockout of IL17A, RORC or IL23R in primary T cells or cell lines can confirm their requirement for Th17 differentiation and effector function.
Point Mutation
Introducing disease-associated point mutations in IL23R or other Th17 genes via CRISPR knock-in allows functional testing of variants linked to autoimmunity.
Knock-in
Knock-in of fluorescent reporters (e.g., IL17A-tdTomato) enables tracking of Th17 cells in vitro and in vivo.
Overexpression
CRISPR-mediated overexpression of IL17A or IL22 can model cytokine-driven inflammation in cell and animal models.
How EDITGENE Supports T-helper 17 type immune response Research
Researchers studying T-helper 17 type immune response-related genes often need to determine whether a candidate gene is causally involved in Th17 differentiation, cytokine production or disease pathogenesis. EDITGENE provides CRISPR-based tools to test these hypotheses with precision.
Contact EDITGENE today to design your custom CRISPR model for T-helper 17 type immune response research.
Frequently Asked Questions About T-helper 17 type immune response
What is GO:0072538?
GO:0072538 is the Gene Ontology term for T-helper 17 type immune response, a biological process driven by Th17 cells and their cytokines IL-17, IL-21 and IL-22.
What genes are involved in T-helper 17 type immune response?
Key genes include IL17A, IL17F, IL21, IL22, RORC, STAT3, IL23R and CCR6 [5,6].
What cytokines do Th17 cells produce?
Th17 cells produce IL-17, IL-21 and IL-22, which mediate inflammatory and barrier responses.
How are Th17 cells differentiated?
Th17 differentiation is driven by cytokines such as IL-6, TGF-β and IL-1β, and requires the transcription factor RORγt [5,6].
What diseases are associated with Th17 responses?
Psoriasis, multiple sclerosis, arthritis, asthma and Hashimoto's thyroiditis are associated with Th17 responses [1,3,5,7,8].
How can I study Th17 cells in the lab?
Flow cytometry, RNA-seq, CRISPR knockout and animal models such as EAE are commonly used.
What is the role of RORγt in Th17 cells?
RORγt (RORC) is a master transcription factor for Th17 differentiation and function.
Can CRISPR be used to study Th17 genes?
Yes, CRISPR knockout, knock-in and overexpression are powerful tools to test gene function in Th17 biology.
What is the link between Th17 and psoriasis?
Th17 cells and IL-17 are central drivers of psoriasis pathogenesis, and targeting IL-17 is an effective therapy.
How does the microbiota influence Th17 responses?
Gut microbiota can promote Th17 responses, and RORγt+ cells can instruct microbiota-specific Treg differentiation.
Conclusion
GO:0072538 T-helper 17 type immune response is a critical biological process that bridges host defense and autoimmune pathology. Its signature cytokines and transcription factors are well-validated drug targets and research foci [1,5]. CRISPR-based models from EDITGENE can accelerate functional studies of Th17-related genes and support the development of new therapeutics.
References
- 1. Yamanaka K et al.. 2021. Pathophysiology of psoriasis: A review.. J Dermatol 48(6):722-731 PMID: 33886133
- 3. Boonpiyathad T et al.. 2019. Immunologic mechanisms in asthma.. Semin Immunol 46:101333 PMID: 31703832
- 4. Stepp MA et al.. 2021. Immune responses to injury and their links to eye disease.. Transl Res 236:52-71 PMID: 34051364
- 5. Zhu X et al.. 2020. CD4 T Helper Cell Subsets and Related Human Immunological Disorders.. Int J Mol Sci 21(21) PMID: 33126494
- 6. Kedmi R et al.. 2022. A RORγt(+) cell instructs gut microbiota-specific T(reg) cell differentiation.. Nature 610(7933):737-743 PMID: 36071167
- 7. Ji T et al.. 2023. T-helper cells and their cytokines in pathogenesis and treatment of asthma.. Front Immunol 14:1149203 PMID: 37377958
- 8. Wrońska K et al.. 2024. The Role of the Immune System in the Course of Hashimoto's Thyroiditis: The Current State of Knowledge.. Int J Mol Sci 25(13) PMID: 38999993
